EcoDrugPlus

Ensembl ID : ENSEEEG00000019335
Gene Symbol: -
Cross references: -
200 Possible Orthologues:

Ensembl ID : ENSEEEG00000023137
Gene Symbol: -
Cross references: -
212 Possible Orthologues:

Ensembl ID : ENSEEEG00000018987
Gene Symbol: -
1 Cross references
214 Possible Orthologues:

Ensembl ID : ENSEEEG00000000339
Gene Symbol: -
Cross references: -
247 Possible Orthologues:

Ensembl ID : ENSEEEG00000000345
Gene Symbol: -
Cross references: -
165 Possible Orthologues:

Ensembl ID : ENSEEEG00000011989
Gene Symbol: -
Cross references: -
620 Possible Orthologues:

Ensembl ID : ENSEEEG00000011985
Gene Symbol: -
Cross references: -
620 Possible Orthologues:

Ensembl ID : ENSEEEG00000001457
Gene Symbol: -
Cross references: -
197 Possible Orthologues:

Ensembl ID : ENSEEEG00000016574
Gene Symbol: -
Cross references: -
180 Possible Orthologues:

Ensembl ID : ENSEEEG00000002074
Gene Symbol: -
Cross references: -
628 Possible Orthologues:

Ensembl ID : ENSEEEG00000002148
Gene Symbol: -
Cross references: -
205 Possible Orthologues:

Ensembl ID : ENSEEEG00000002073
Gene Symbol: -
1 Cross references
185 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).